What AI says about Frazier Life Sciences

Frazier Life Sciences is a biotech investment firm that manages over $6.9 billion in assets across venture and public strategies. The firm partners with and builds companies developing novel therapeutics, having created over 25 companies and supported more than 75 FDA-approved drugs since 2015.

AI mentioned Frazier Life Sciences in September 2026.

Questions and answers

Frazier Life Sciences in AI answers

I'm looking for seed investors in Boston who specifically back biotech and life sciences startups.

ChatGPTChatGPTNo answer mentioning Frazier Life Sciences
Google AI ModeGoogle AI Mode· Sep 20, 2026
Frazier Life Sciences : Focuses heavily on therapeutics, investing from seed and series A onwards into innovative biotech companies.

Sites AI cites

None of these answers cited frazierls.com. AI cited biotechvclist.com and signal.nfx.com.